Animal behavior models of the mechanisms underlying antipsychotic atypicality

This publication has 77 references indexed in Scilit:

• The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia
  Neuropsychopharmacology, 1999
• Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment
  The British Journal of Psychiatry, 1998
• Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
• Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics
  Neuropsychopharmacology, 1997
• Phencyclidine-induced stereotyped behaviour and social isolation in rats
  Behavioural Pharmacology, 1996
• The selective 5-HT2a receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse ? implications for psychosis
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1995
• Neurochemical and in vivo pharmacological profile of sertindole, a limbic‐selective neuroleptic compound
  Drug Development Research, 1991
• The PAW test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism
  Life Sciences, 1988
• The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings
  Pharmacology Biochemistry and Behavior, 1986
• Disorders of attention and perception in early schizophrenia
  Psychology and Psychotherapy: Theory, Research and Practice, 1961